Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Epithelial HIF-1α/claudin-1 axis regulates barrier dysfunction in eosinophilic esophagitis
Joanne C. Masterson, … , Sean P. Colgan, Glenn T. Furuta
Joanne C. Masterson, … , Sean P. Colgan, Glenn T. Furuta
Published July 2, 2019
Citation Information: J Clin Invest. 2019;129(8):3224-3235. https://doi.org/10.1172/JCI126744.
View: Text | PDF
Research Article Gastroenterology

Epithelial HIF-1α/claudin-1 axis regulates barrier dysfunction in eosinophilic esophagitis

  • Text
  • PDF
Abstract

Epithelial barrier dysfunction is a significant factor in many allergic diseases, including eosinophilic esophagitis (EoE). Infiltrating leukocytes and tissue adaptations increase metabolic demands and decrease oxygen availability at barrier surfaces. Understanding of how these processes impact barrier is limited, particularly in allergy. Here, we identified a regulatory axis whereby the oxygen-sensing transcription factor HIF-1α orchestrated epithelial barrier integrity, selectively controlling tight junction CLDN1 (claudin-1). Prolonged experimental hypoxia or HIF1A knockdown suppressed HIF-1α–dependent claudin-1 expression and epithelial barrier function, as documented in 3D organotypic epithelial cultures. L2-IL5OXA mice with EoE-relevant allergic inflammation displayed localized eosinophil oxygen metabolism, tissue hypoxia, and impaired claudin-1 barrier via repression of HIF-1α/claudin-1 signaling, which was restored by transgenic expression of esophageal epithelial-targeted stabilized HIF-1α. EoE patient biopsy analysis identified a repressed HIF-1α/claudin-1 axis, which was restored via pharmacologic HIF-1α stabilization ex vivo. Collectively, these studies reveal HIF-1α’s critical role in maintaining barrier and highlight the HIF-1α/claudin-1 axis as a potential therapeutic target for EoE.

Authors

Joanne C. Masterson, Kathryn A. Biette, Juliet A. Hammer, Nathalie Nguyen, Kelley E. Capocelli, Bejan J. Saeedi, Rachel F. Harris, Shahan D. Fernando, Lindsay B. Hosford, Caleb J. Kelly, Eric L. Campbell, Stefan F. Ehrentraut, Faria N. Ahmed, Hiroshi Nakagawa, James J. Lee, Eóin N. McNamee, Louise E. Glover, Sean P. Colgan, Glenn T. Furuta

×

Figure 5

Prolonged and sustained hypoxia mediated by esophageal eosinophilia in experimental EoE leads to a dysregulated HIF-1α/CLDN1 signaling axis.

Options: View larger image (or click on image) Download as PowerPoint
Prolonged and sustained hypoxia mediated by esophageal eosinophilia in e...
(A) L2-IL5 transgenic mice and WT littermate controls were exposed to OXA-induced esophagitis and assessed for esophageal eosinophils using MBP immunohistochemistry or immunofluorescence for Siglec-F in conjunction with Hypoxyprobe-1 (Hx-1) (n = 3–9). Eosinophils were enumerated based on MBP staining per high-power field (HPF). Primary peripheral blood human eosinophils were isolated and stimulated in the presence or absence of PMA and assessed for oxygen consumption over time (minutes) (n = 3). Scale bars: 20 μm. (B) L2-IL5 transgenic mice and WT littermate controls were exposed to OXA-induced esophagitis and assessed for tissue oxygen tension by Hypoxyprobe-1 (Hx-1) immunofluorescent staining, which was quantified to measure the area of tissue under hypoxic constraints (n = 9 per group). Scale bars: 50 μm. (C) Whole esophageal tissues from OXA-challenged L2-IL5 and WT littermate control mice were assessed for HIF-1α protein expression by Western blot and quantified by densitometry (n = 4–6). WT ODD-LUC and L2-IL5/ODD-LUC luciferase reporter mice were challenged with OXA-induced esophagitis and assessed by luciferase assay for HIF/luciferase activity relative to total tissue protein (n = 12). OXA-challenged L2-IL5 and WT littermate control mice were assessed for HIF1A and GLUT1 mRNA expression by real-time RT-PCR (n = 5). (D) OXA-challenged L2-IL5 and WT littermate control mice were assessed for histologic activity scores from H&E-stained esophageal tissues (n = 8–9). Scale bars: 50 μm (top); 20 μm (bottom). (E) Whole esophageal tissues were assessed for claudin-1 protein by Western blot and quantified by densitometry (n = 11), and were assessed for CLDN1 mRNA transcript expression by real-time RT-PCR (n = 5). Representative blot is presented. Statistical significance was assessed using Students’ t test. *P < 0.05, **P < 0.01, ***P < 0.001. Data are expressed as means ± SEM and represent a minimum of 3 experimental repeats.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts